{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:39:42Z","timestamp":1792622382253,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["advancesinanesthesia.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Anesthesia"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.aan.2026.06.009","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:25:17Z","timestamp":1784838317000},"page":"189-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of Patients on Medications for Opioid Use Disorder in the Perioperative or Peripartum Setting"],"prefix":"10.1016","volume":"44","author":[{"given":"Breta","family":"Awuku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara S.","family":"Oberhelman-Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aan.2026.06.009_bib1","series-title":"Understanding the opioid overdose epidemic","year":"2025"},{"key":"10.1016\/j.aan.2026.06.009_bib2","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.aan.2026.06.009_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.aan.2026.06.009_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.aan.2026.06.009_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amepre.2023.01.037","article-title":"Buprenorphine after nonfatal opioid overdose: reduced mortality risk in medicare disability beneficiaries","volume":"65","author":"Samples","year":"2023","journal-title":"Am J Prev Med"},{"issue":"10279","key":"10.1016\/j.aan.2026.06.009_bib6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(21)00391-3","article-title":"The opioid crisis and HIV in the USA: deadly synergies","volume":"397","author":"Hodder","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.aan.2026.06.009_bib7","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1093\/cid\/ciz693","article-title":"Low hepatitis C reinfection following direct-acting antiviral therapy among people who inject drugs on opioid agonist therapy","volume":"70","author":"Akiyama","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.aan.2026.06.009_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.34540","article-title":"Buprenorphine dose and time to discontinuation among patients with opioid use disorder in the era of fentanyl","volume":"6","author":"Chambers","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.aan.2026.06.009_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.35478","article-title":"Association of daily doses of buprenorphine with urgent health care utilization","volume":"7","author":"Axeen","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"16","key":"10.1016\/j.aan.2026.06.009_bib10","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1056\/NEJMc2312906","article-title":"Buprenorphine dispensing after elimination of the waiver requirement","volume":"390","author":"Chua","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.aan.2026.06.009_bib11","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3122\/jabfm.2024.240453R1","article-title":"Examining removal of federal waiver restrictions to prescribing buprenorphine in primary care","volume":"38","author":"Simon","year":"2025","journal-title":"J Am Board Fam Med"},{"issue":"5","key":"10.1016\/j.aan.2026.06.009_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.amepre.2025.108055","article-title":"Buprenorphine dispensation after X-waiver elimination by clinician specialty","volume":"69","author":"Stone","year":"2025","journal-title":"Am J Prev Med"},{"issue":"3","key":"10.1016\/j.aan.2026.06.009_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.yrtph.2010.12.007","article-title":"Uniform assessment and ranking of opioid mu receptor binding constants for selected opioid drugs","volume":"59","author":"Volpe","year":"2011","journal-title":"Regul Toxicol Pharmacol"},{"issue":"4","key":"10.1016\/j.aan.2026.06.009_bib14","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/pm\/pnz356","article-title":"Understanding buprenorphine for use in chronic pain: expert opinion","volume":"21","author":"Webster","year":"2020","journal-title":"Pain Med"},{"issue":"12","key":"10.1016\/j.aan.2026.06.009_bib15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11864-021-00910-8","article-title":"Treating chronic pain with buprenorphine-the practical guide","volume":"22","author":"Case","year":"2021","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"10.1016\/j.aan.2026.06.009_bib16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1186\/s13063-018-3055-z","article-title":"Single high-dose buprenorphine for opioid craving during withdrawal","volume":"19","author":"Ahmadi","year":"2018","journal-title":"Trials"},{"issue":"4","key":"10.1016\/j.aan.2026.06.009_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1570159043359477","article-title":"Buprenorphine: a unique drug with complex pharmacology","volume":"2","author":"Lutfy","year":"2004","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"10.1016\/j.aan.2026.06.009_bib18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.aan.2026.06.009_bib19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40268-023-00443-5","article-title":"A guide to expanding the use of buprenorphine beyond standard initiations for opioid use disorder","volume":"23","author":"Miller","year":"2023","journal-title":"Drugs R&D"},{"key":"10.1016\/j.aan.2026.06.009_bib20","series-title":"Buprenorphine","author":"Kumar","year":"2025"},{"issue":"12","key":"10.1016\/j.aan.2026.06.009_bib21","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1007\/s11606-020-06115-3","article-title":"Treating perioperative and acute pain in patients on buprenorphine: narrative literature review and practice recommendations","volume":"35","author":"Buresh","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"6","key":"10.1016\/j.aan.2026.06.009_bib22","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.mayocp.2019.10.007","article-title":"A practical approach for the management of the mixed opioid agonist-antagonist buprenorphine during acute pain and surgery","volume":"95","author":"Warner","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"10.1016\/j.aan.2026.06.009_bib23","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/rapm-2021-103007","article-title":"Buprenorphine management in the perioperative period: educational review and recommendations from a multisociety expert panel","volume":"46","author":"Kohan","year":"2021","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/j.aan.2026.06.009_bib24","author":"Snyder"},{"key":"10.1016\/j.aan.2026.06.009_bib25","author":"Selvamani"},{"issue":"5","key":"10.1016\/j.aan.2026.06.009_bib26","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDccon2300275","article-title":"How do i manage acute pain for patients prescribed buprenorphine for opioid use disorder?","volume":"3","author":"Sandhu","year":"2024","journal-title":"NEJM Evid"},{"issue":"2S Suppl 1","key":"10.1016\/j.aan.2026.06.009_bib27","first-page":"1","article-title":"The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update","volume":"14","year":"2020","journal-title":"J Addict Med"},{"issue":"3","key":"10.1016\/j.aan.2026.06.009_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.anclin.2018.04.002","article-title":"Perioperative considerations for the patient with opioid use disorder on buprenorphine, methadone, or naltrexone maintenance therapy","volume":"36","author":"Harrison","year":"2018","journal-title":"Anesthesiol Clin"},{"key":"10.1016\/j.aan.2026.06.009_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2014.12.011","article-title":"Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes","volume":"52","author":"Bentzley","year":"2015","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"10.1016\/j.aan.2026.06.009_bib30","doi-asserted-by":"crossref","first-page":"E163","DOI":"10.36076\/ppj.2020\/23\/E163","article-title":"Continuation of buprenorphine to facilitate postoperative pain management for patients on buprenorphine opioid agonist therapy","volume":"23","author":"Mehta","year":"2020","journal-title":"Pain Physician"},{"issue":"7","key":"10.1016\/j.aan.2026.06.009_bib31","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/pm\/pny217","article-title":"Perioperative management of buprenorphine: solving the conundrum","volume":"20","author":"Quaye","year":"2019","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.aan.2026.06.009_bib32","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1016\/j.bja.2019.03.044","article-title":"Perioperative pain and addiction interdisciplinary network (PAIN) clinical practice advisory for perioperative management of buprenorphine: results of a modified Delphi process","volume":"123","author":"Goel","year":"2019","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.aan.2026.06.009_bib33","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s00213-005-0023-6","article-title":"Buprenorphine\/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers","volume":"181","author":"Comer","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.aan.2026.06.009_bib34","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.npp.1300251","article-title":"Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers","volume":"28","author":"Greenwald","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.aan.2026.06.009_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.07.035","article-title":"Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy","volume":"144","author":"Greenwald","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.aan.2026.06.009_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.mcna.2021.09.001","article-title":"Perioperative buprenorphine management: a multidisciplinary approach","volume":"106","author":"Hickey","year":"2022","journal-title":"Med Clin North Am"},{"issue":"6","key":"10.1016\/j.aan.2026.06.009_bib39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/jcpt.12196","article-title":"The clinical analgesic efficacy of buprenorphine","volume":"39","author":"Raffa","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.aan.2026.06.009_bib40","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2147\/JPR.S160255","article-title":"Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials","volume":"11","author":"Meske","year":"2018","journal-title":"J Pain Res"},{"issue":"1\u20132","key":"10.1016\/j.aan.2026.06.009_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pain.2005.06.030","article-title":"Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model","volume":"118","author":"Koppert","year":"2005","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.aan.2026.06.009_bib42","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/rapm-2024-106304","article-title":"Buprenorphine versus full agonist opioids for acute postoperative pain management: an infographic","volume":"51","author":"Hickey","year":"2025","journal-title":"Reg Anesth Pain Med"},{"issue":"1","key":"10.1016\/j.aan.2026.06.009_bib43","first-page":"362","article-title":"Clinical pearls for buprenorphine treatment","volume":"11","author":"Walton","year":"2021","journal-title":"Prim Health Care"},{"issue":"2","key":"10.1016\/j.aan.2026.06.009_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1213\/ANE.0000000000002718","article-title":"Treatment of chronic pain with various buprenorphine formulations: a systematic review of clinical studies","volume":"127","author":"Aiyer","year":"2018","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.aan.2026.06.009_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/AJP.0b013e31815ca2b4","article-title":"Buprenorphine: new tricks with an old molecule for pain management","volume":"24","author":"Heit","year":"2008","journal-title":"Clin J Pain"},{"issue":"6","key":"10.1016\/j.aan.2026.06.009_bib46","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadone--metabolism, pharmacokinetics and interactions","volume":"50","author":"Ferrari","year":"2004","journal-title":"Pharmacol Res"},{"issue":"15","key":"10.1016\/j.aan.2026.06.009_bib47","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/ajhp\/zxab166","article-title":"Methadone bioavailability and dose conversion implications with intravenous and enteral administration: a scoping review","volume":"78","author":"Liu","year":"2021","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"10.1016\/j.aan.2026.06.009_bib48","first-page":"1","article-title":"Regional differences in the drugs most frequently involved in drug overdose deaths: united States, 2017","volume":"68","author":"Hedegaard","year":"2019","journal-title":"Natl Vital Stat Rep"},{"issue":"2","key":"10.1016\/j.aan.2026.06.009_bib49","doi-asserted-by":"crossref","first-page":"320","DOI":"10.15585\/mmwr.mm6612a2","article-title":"Methadone prescribing and overdose and the association with medicaid preferred drug list policies - united States, 2007-2014","volume":"66","author":"Faul","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.aan.2026.06.009_bib50","article-title":"Methadone Treatment for Opioid Use Disorder: Improving Access Through Regulatory and Legal Change: Proceedings of a Workshop","year":"2022"},{"issue":"5","key":"10.1016\/j.aan.2026.06.009_bib51","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF03016532","article-title":"Review article: perioperative pain management of patients on methadone therapy","volume":"52","author":"Peng","year":"2005","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.aan.2026.06.009_bib52","doi-asserted-by":"crossref","DOI":"10.52965\/001c.129552","article-title":"Methadone for chronic pain: a review of pharmacology, efficacy, and safety concerns","volume":"13","author":"Brown","year":"2025","journal-title":"Health Psychol Res"},{"key":"10.1016\/j.aan.2026.06.009_bib53","author":"Snyder"},{"issue":"3","key":"10.1016\/j.aan.2026.06.009_bib54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2165\/00003088-197601030-00004","article-title":"The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone","volume":"1","author":"Berkowitz","year":"1976","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.aan.2026.06.009_bib55","series-title":"Naltrexone","author":"Singh","year":"2025"},{"issue":"8","key":"10.1016\/j.aan.2026.06.009_bib56","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/jama.2018.11406","article-title":"Diagnosis and pharmacotherapy of alcohol use disorder: a review","volume":"320","author":"Kranzler","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.aan.2026.06.009_bib57","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","article-title":"Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population","volume":"85","author":"Morgan","year":"2018","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"10.1016\/j.aan.2026.06.009_bib58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1176\/appi.ajp.2018.17070732","article-title":"A randomized trial comparing extended-release injectable suspension and oral naltrexone, both combined with behavioral therapy, for the treatment of opioid use disorder","volume":"176","author":"Sullivan","year":"2019","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.aan.2026.06.009_bib59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s13181-015-0512-x","article-title":"Naltrexone: not just for opioids anymore","volume":"12","author":"Sudakin","year":"2016","journal-title":"J Med Toxicol"},{"issue":"4","key":"10.1016\/j.aan.2026.06.009_bib60","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/jat\/bku019","article-title":"Naltrexone metabolism and concomitant drug concentrations in chronic pain patients","volume":"38","author":"Liu","year":"2014","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.aan.2026.06.009_bib61","author":"Gaspar"},{"issue":"3","key":"10.1016\/j.aan.2026.06.009_bib62","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1530-0277.2006.00052.x","article-title":"Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone","volume":"30","author":"Dunbar","year":"2006","journal-title":"Alcohol Clin Exp Res"},{"issue":"11","key":"10.1016\/j.aan.2026.06.009_bib63","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1213\/XAA.0000000000000069","article-title":"Challenges in the perioperative management of the patient receiving extended-release naltrexone","volume":"3","author":"Curatolo","year":"2014","journal-title":"A A Case Rep"},{"issue":"3","key":"10.1016\/j.aan.2026.06.009_bib64","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/00952990.2011.653426","article-title":"Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice","volume":"38","author":"Sigmon","year":"2012","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.aan.2026.06.009_bib65","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1213\/ANE.0000000000003477","article-title":"Opioid use disorders: perioperative management of a special population","volume":"127","author":"Ward","year":"2018","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.aan.2026.06.009_bib66","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/ALN.0b013e31823c1030","article-title":"Practice guidelines for acute pain management in the perioperative setting: an updated report by the American society of anesthesiologists task force on acute pain management","volume":"116","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.aan.2026.06.009_bib67","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2147\/TCRM.S141332","article-title":"The challenge of perioperative pain management in opioid-tolerant patients","volume":"13","author":"Coluzzi","year":"2017","journal-title":"Ther Clin Risk Manag"},{"issue":"18","key":"10.1016\/j.aan.2026.06.009_bib68","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1001\/jama.290.18.2455","article-title":"Efficacy of postoperative epidural analgesia: a meta-analysis","volume":"290","author":"Block","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.aan.2026.06.009_bib69","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1213\/01.ANE.0000181289.09675.7D","article-title":"Does continuous peripheral nerve block provide superior pain control to opioids? A meta-analysis","volume":"102","author":"Richman","year":"2006","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.aan.2026.06.009_bib70","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/bja\/aen368","article-title":"Benefit and risk of intrathecal morphine without local anaesthetic in patients undergoing major surgery: meta-analysis of randomized trials","volume":"102","author":"Meylan","year":"2009","journal-title":"Br J Anaesth"},{"issue":"6","key":"10.1016\/j.aan.2026.06.009_bib71","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/AAP.0b013e31826c351b","article-title":"Continuous peripheral nerve block compared with single-injection peripheral nerve block: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Bingham","year":"2012","journal-title":"Reg Anesth Pain Med"},{"issue":"3","key":"10.1016\/j.aan.2026.06.009_bib72","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/ALN.0b013e3181e90914","article-title":"Intraoperative ketamine reduces perioperative opiate consumption in opiate-dependent patients with chronic back pain undergoing back surgery","volume":"113","author":"Loftus","year":"2010","journal-title":"Anesthesiology"},{"issue":"12","key":"10.1016\/j.aan.2026.06.009_bib73","article-title":"Perioperative intravenous ketamine for acute postoperative pain in adults","volume":"12","author":"Brinck","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.aan.2026.06.009_bib74","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.3390\/jcm12093256","article-title":"Narrative review: low-dose ketamine for pain management","volume":"12","author":"Riccardi","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.aan.2026.06.009_bib75","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4103\/0970-9185.182105","article-title":"Dexmedetomidine versus midazolam as adjuvants to intrathecal bupivacaine: a clinical comparison","volume":"32","author":"Shukla","year":"2016","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.aan.2026.06.009_bib76","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/bja\/aew411","article-title":"Evidence basis for using perineural dexmedetomidine to enhance the quality of brachial plexus nerve blocks: a systematic review and meta-analysis of randomized controlled trials","volume":"118","author":"Vorobeichik","year":"2017","journal-title":"Br J Anaesth"},{"issue":"7","key":"10.1016\/j.aan.2026.06.009_bib77","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.pain.2013.03.029","article-title":"Is intraoperative dexmedetomidine a new option for postoperative pain treatment? A meta-analysis of randomized controlled trials","volume":"154","author":"Schnabel","year":"2013","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.aan.2026.06.009_bib78","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11916-020-00853-z","article-title":"Dexmedetomidine in enhanced recovery after surgery (ERAS) protocols for postoperative pain","volume":"24","author":"Kaye","year":"2020","journal-title":"Curr Pain Headache Rep"},{"issue":"11","key":"10.1016\/j.aan.2026.06.009_bib79","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/bjs.6375","article-title":"Meta-analysis of intravenous lidocaine and postoperative recovery after abdominal surgery","volume":"95","author":"Marret","year":"2008","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.aan.2026.06.009_bib80","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s12630-010-9407-0","article-title":"Perioperative intravenous lidocaine infusion for postoperative pain control: a meta-analysis of randomized controlled trials","volume":"58","author":"Vigneault","year":"2011","journal-title":"Can J Anaesth"},{"issue":"9","key":"10.1016\/j.aan.2026.06.009_bib81","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2165\/10898560-000000000-00000","article-title":"Impact of intravenous lidocaine infusion on postoperative analgesia and recovery from surgery: a systematic review of randomized controlled trials","volume":"70","author":"McCarthy","year":"2010","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.aan.2026.06.009_bib82","first-page":"CD009642","article-title":"Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery","author":"Kranke","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.aan.2026.06.009_bib83","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11916-025-01422-y","article-title":"Clinical efficacy of magnesium in perioperative pain management: a narrative review","volume":"29","author":"Ahmadzadeh","year":"2025","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"10.1016\/j.aan.2026.06.009_bib84","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/ALN.0b013e318297630d","article-title":"Perioperative systemic magnesium to minimize postoperative pain: a meta-analysis of randomized controlled trials","volume":"119","author":"De Oliveira","year":"2013","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.aan.2026.06.009_bib85","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2174\/138920012800166607","article-title":"Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn","volume":"13","author":"Antonucci","year":"2012","journal-title":"Curr Drug Metab"},{"issue":"2","key":"10.1016\/j.aan.2026.06.009_bib86","first-page":"E153","article-title":"Effect of preemptive acetaminophen on opioid consumption: a meta-analysis","volume":"24","author":"Xuan","year":"2021","journal-title":"Pain Physician"},{"issue":"2","key":"10.1016\/j.aan.2026.06.009_bib87","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/ALN.0000000000001700","article-title":"Acetaminophen metabolite N-Acylphenolamine induces analgesia via transient receptor potential vanilloid 1 receptors expressed on the primary afferent terminals of C-fibers in the spinal dorsal horn","volume":"127","author":"Ohashi","year":"2017","journal-title":"Anesthesiology"},{"key":"10.1016\/j.aan.2026.06.009_bib88","first-page":"47","article-title":"Curb your enthusiasm: should gabapentinoids be a routine component of multimodal analgesia? ASRA pain medicine news","author":"Farhat","year":"2022","journal-title":"American Society of Regional Anesthesia and Pain Medicine"},{"issue":"4","key":"10.1016\/j.aan.2026.06.009_bib89","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyaf137","article-title":"Analgesic opioids in pregnancy and placental malperfusion-related disorders: a population-based cohort study","volume":"54","author":"Brett","year":"2025","journal-title":"Int J Epidemiol"},{"issue":"5","key":"10.1016\/j.aan.2026.06.009_bib90","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/aje\/kwab132","article-title":"Ischemic placental disease, preterm delivery, and their association with opioid use during pregnancy","volume":"191","author":"Esposito","year":"2022","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.aan.2026.06.009_bib91","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1097\/AOG.0000000000006066","article-title":"ACOG clinical practice update: elimination of the DATA-waiver program","volume":"146","year":"2025","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.aan.2026.06.009_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)21130-2","article-title":"Altered methadone pharmacokinetics in methadone-maintained pregnant women","volume":"233","author":"Pond","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"10.1016\/j.aan.2026.06.009_bib95","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/j.1360-0443.2010.03120.x","article-title":"Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis","volume":"105","author":"Cleary","year":"2010","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.aan.2026.06.009_bib96","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1479-828X.2001.tb01322.x","article-title":"Obstetric and neonatal outcomes associated with maternal naltrexone exposure","volume":"41","author":"Hulse","year":"2001","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"9","key":"10.1016\/j.aan.2026.06.009_bib97","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.clinthera.2019.07.003","article-title":"Naltrexone treatment for pregnant women with opioid use disorder compared with matched buprenorphine control subjects","volume":"41","author":"Wachman","year":"2019","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.aan.2026.06.009_bib98","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/ADM.0000000000001293","article-title":"Case series of individuals treated with naltrexone during pregnancy for opioid And\/or alcohol use disorder","volume":"18","author":"Wachman","year":"2024","journal-title":"J Addict Med"},{"issue":"1","key":"10.1016\/j.aan.2026.06.009_bib99","doi-asserted-by":"crossref","first-page":"83.e1","DOI":"10.1016\/j.ajog.2019.07.037","article-title":"Use of naltrexone in treating opioid use disorder in pregnancy","volume":"222","author":"Towers","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.aan.2026.06.009_bib100","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1213\/ANE.0000000000007237","article-title":"Consensus statement on pain management for pregnant patients with opioid-use disorder from the society for obstetric anesthesia and perinatology, society for maternal-fetal medicine, and American society of regional anesthesia and pain medicine","volume":"140","author":"Lim","year":"2025","journal-title":"Anesth Analg"},{"issue":"8","key":"10.1016\/j.aan.2026.06.009_bib101","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/anae.15756","article-title":"Comparison of ultra-low, low and high concentration local anaesthetic for labour epidural analgesia: a systematic review and network meta-analysis","volume":"77","author":"Halliday","year":"2022","journal-title":"Anaesthesia"},{"issue":"9","key":"10.1016\/j.aan.2026.06.009_bib102","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s12630-013-9981-z","article-title":"The effect of low concentrations versus high concentrations of local anesthetics for labour analgesia on obstetric and anesthetic outcomes: a meta-analysis","volume":"60","author":"Sultan","year":"2013","journal-title":"Can J Anaesth"},{"issue":"9","key":"10.1016\/j.aan.2026.06.009_bib103","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ejpain.2010.03.002","article-title":"Intrapartum and postpartum analgesia for women maintained on buprenorphine during pregnancy","volume":"14","author":"Meyer","year":"2010","journal-title":"Eur J Pain"},{"issue":"5S","key":"10.1016\/j.aan.2026.06.009_bib104","doi-asserted-by":"crossref","first-page":"S1246","DOI":"10.1016\/j.ajog.2023.03.003","article-title":"Pharmacologic and nonpharmacologic options for pain relief during labor: an expert review","volume":"228","author":"Zuarez-Easton","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1016\/j.aan.2026.06.009_bib105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.AOG.0000275288.47258.e0","article-title":"Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy","volume":"110","author":"Meyer","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.aan.2026.06.009_bib106","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1213\/ANE.0000000000006281","article-title":"Substance use disorders: basic overview for the anesthesiologist","volume":"137","author":"Jimenez Ruiz","year":"2023","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.aan.2026.06.009_bib107","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/00952990.2012.696168","article-title":"Co-occurring psychiatric symptoms in opioid-dependent women: the prevalence of antenatal and postnatal depression","volume":"38","author":"Holbrook","year":"2012","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"11","key":"10.1016\/j.aan.2026.06.009_bib108","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.46486","article-title":"Trends in postpartum depression by race, ethnicity, and prepregnancy body mass index","volume":"7","author":"Khadka","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.aan.2026.06.009_bib109","first-page":"1060","article-title":"Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants","volume":"102","author":"Welle-Strand","year":"2013","journal-title":"Acta Paediatr"},{"issue":"10","key":"10.1016\/j.aan.2026.06.009_bib110","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/bfm.2023.29256.abm","article-title":"Academy of breastfeeding medicine clinical protocol #21: breastfeeding in the setting of substance use and substance use disorder (revised 2023)","volume":"18","author":"Harris","year":"2023","journal-title":"Breastfeed Med"},{"issue":"2","key":"10.1016\/j.aan.2026.06.009_bib111","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1097\/AOG.0000000000004253","article-title":"Breastfeeding Challenges: ACOG Committee Opinion, Number 820","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.aan.2026.06.009_bib112","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/peds.2011-3212","article-title":"Newborn, American academy of P. Neonatal drug withdrawal","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics"},{"issue":"24","key":"10.1016\/j.aan.2026.06.009_bib113","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Advances in Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0737614626000171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0737614626000171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:03:56Z","timestamp":1792620236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0737614626000171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0737614626000171"],"URL":"https:\/\/doi.org\/10.1016\/j.aan.2026.06.009","relation":{},"ISSN":["0737-6146"],"issn-type":[{"value":"0737-6146","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Patients on Medications for Opioid Use Disorder in the Perioperative or Peripartum Setting","name":"articletitle","label":"Article Title"},{"value":"Advances in Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aan.2026.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}